BlackRock’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-5,723
| Closed | -$100K | – | 5411 |
|
|
2020
Q4 | $100K | Sell |
5,723
-6,243
| -52% | -$87.6K | ﹤0.01% | 4590 |
|
|
2020
Q3 | $140K | Sell |
11,966
-7,001
| -37% | -$92.9K | ﹤0.01% | 4471 |
|
|
2020
Q2 | $247K | Sell |
18,967
-988
| -5% | -$11.9K | ﹤0.01% | 4336 |
|
|
2020
Q1 | $185K | Buy |
19,955
+5,695
| +40% | +$79.6K | ﹤0.01% | 4244 |
|
|
2019
Q4 | $237K | Buy |
14,260
+5,507
| +63% | +$89.3K | ﹤0.01% | 4295 |
|
|
2019
Q3 | $146K | Sell |
8,753
-50,763
| -85% | -$702K | ﹤0.01% | 4369 |
|
|
2019
Q2 | $818K | Sell |
59,516
-1,217,999
| -95% | -$18.6M | ﹤0.01% | 4069 |
|
|
2019
Q1 | $22M | Sell |
1,277,515
-23,236
| -2% | -$368K | ﹤0.01% | 2700 |
|
|
2018
Q4 | $16.6M | Sell |
1,300,751
-9,347
| -0.7% | -$142K | ﹤0.01% | 2819 |
|
|
2018
Q3 | $21.3M | Buy |
1,310,098
+30,774
| +2% | +$440K | ﹤0.01% | 2839 |
|
|
2018
Q2 | $16.5M | Buy |
1,279,324
+116,814
| +10% | +$1.58M | ﹤0.01% | 2972 |
|
|
2018
Q1 | $14.5M | Buy |
1,162,510
+74,565
| +7% | +$908K | ﹤0.01% | 2936 |
|
|
2017
Q4 | $15.2M | Buy |
1,087,945
+65,718
| +6% | +$963K | ﹤0.01% | 2923 |
|
|
2017
Q3 | $17.2M | Sell |
1,022,227
-7,134
| -0.7% | -$116K | ﹤0.01% | 2888 |
|
|
2017
Q2 | $17.3M | Buy |
1,029,361
+25,954
| +3% | +$388K | ﹤0.01% | 2873 |
|
|
2017
Q1 | $15.5M | Buy |
1,003,407
+1,001,222
| +45,823% | +$14.3M | ﹤0.01% | 2905 |
|
|
2016
Q4 | $33K | Sell |
2,185
-278
| -11% | -$3.9K | ﹤0.01% | 3106 |
|
|
2016
Q3 | $31K | Buy |
2,463
+402
| +20% | +$4.04K | ﹤0.01% | 3163 |
|
|
2016
Q2 | $18K | Sell |
2,061
-1,021
| -33% | -$10K | ﹤0.01% | 3299 |
|
|
2016
Q1 | $30K | Buy |
3,082
+2,157
| +233% | +$22.1K | ﹤0.01% | 2643 |
|
|
2015
Q4 | $11K | Buy |
925
+622
| +205% | +$7.7K | ﹤0.01% | 2871 |
|
|
2015
Q3 | $4K | Hold |
303
| – | – | ﹤0.01% | 3098 |
|
|
2015
Q2 | $4K | Hold |
303
| – | – | ﹤0.01% | 3171 |
|
|
2015
Q1 | $4K | Buy |
+303
| New | +$4.12K | ﹤0.01% | 3081 |
|
|
2014
Q1 | – | Sell |
-151
| Closed | -$3K | – | 3189 |
|
|
2013
Q4 | $3K | Buy |
+151
| New | +$2.67K | ﹤0.01% | 3117 |
|
BlackRock's OXFD Position: Q1 2021 in Review
BlackRock sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 5,723 shares — an estimated $100K sold.
BlackRock first reported a position in OXFD in Q4 2013 and held it in 25 quarters. The position peaked at $22M in Q1 2019. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.
- BlackRock reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
- BlackRock sold 5,723 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $100K.
- BlackRock first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2013 and held it in 25 quarters.
- BlackRock's Oxford Immunotec Global PLC Ordinary Shares position peaked at $22M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.
Based on BlackRock's 13F filing for Q1 2021, filed 7 May 2021.